How I manage anemia related to myelofibrosis and its treatment regimens Srdan Verstovsek Review Article Open access 14 February 2023 Pages: 689 - 698
ERCC6L2-related disease: a novel entity of bone marrow failure disorder with high risk of clonal evolution Francesco BaccelliDavide LeardiniRiccardo Masetti Review Article Open access 15 February 2023 Pages: 699 - 705
Neonatal hematological parameters: the translational aspect of developmental hematopoiesis Rozeta SokouStavroula ParastatidouArgirios E. Tsantes Review Article 27 February 2023 Pages: 707 - 714
Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus Dražen PulanićAngelika BátorováMaria Podolak-Dawidziak Original Article Open access 24 February 2023 Pages: 715 - 727
Serum cytokine pattern in children with hemophagocytic lymphohistiocytosis Wenxin OuYunze ZhaoRui Zhang Original Article 16 February 2023 Pages: 729 - 739
Maternal factors associated with iron deficiency without anaemia in early pregnancy: ECLIPSES study Lucía Iglesias-VázquezMercedes GimenoVictoria Arija Original Article Open access 15 February 2023 Pages: 741 - 748
Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States Amer M. ZeidanDaniel A. PollyeaClara Chen Original Article Open access 03 February 2023 Pages: 749 - 754
Amsacrine-based induction therapy in AML patients with cardiac comorbidities: a retrospective single-center analysis David KuronAlexander PohlmannJan-Henrik Mikesch Original Article Open access 07 February 2023 Pages: 755 - 760
Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysis Marco CerranoSylvie ChevretEtienne Lengliné Original Article 11 February 2023 Pages: 761 - 768
Impact of gemtuzumab ozogamicin consolidation on hematopoietic stem cells (HSCs) mobilization in AML: analysis of 20 patients Salvatore PerroneSaveria CapriaGiuseppe Cimino Original Article 16 February 2023 Pages: 769 - 775
Molecular genetics and management of world health organization defined atypical chronic myeloid leukemia Yingxin SunQinrong WangSuning Chen Original Article 03 February 2023 Pages: 777 - 785
Value of the FDP/FIB ratio in predicting early severe bleeding events in patients with newly diagnosed acute promyelocytic leukemia Shanshan LiYujuan GaoYanhua Su Original Article 07 February 2023 Pages: 787 - 794
Prognostic value of interim 18F-FDG PET/CT in adult follicular lymphoma treated with R-CHOP Na SunWenli QiaoJinhua Zhao Original Article 20 February 2023 Pages: 795 - 800
Characteristics of inpatients with newly diagnosed multiple myeloma in hematology, nephrology, and orthopedic departments Yanjie ZhangJuan PanBo Shen Original Article 08 February 2023 Pages: 801 - 809
COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group Martin ŠimkovičPeter TurcsányiMichael Doubek Original Article 27 February 2023 Pages: 811 - 817
Humoral response to mRNA-based COVID-19 vaccine and booster effect of a third dose in patients with mature T cell and NK-cell neoplasms Mirei KobayashiAkio MoriTakeshi Kondo Original Article Open access 02 March 2023 Pages: 819 - 827
Central nervous system involvement at initial diagnosis of extranodal NK/T-cell lymphoma: a retrospective study of a consecutive 12-year case series Wanchun WuKexin RenLiqun Zou Original Article 02 February 2023 Pages: 829 - 839
Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the “RTL” (regional Tuscan lymphoma network) Emanuele CenciniIlaria RomanoAlberto Fabbri Original Article 03 February 2023 Pages: 841 - 849
Low T3 syndrome as a predictor of poor outcomes in patients with follicular lymphoma Lian-Guo XueHao-Rui ShenWei Xu Original Article 03 February 2023 Pages: 851 - 862
Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA Kenshi SuzukiAshutosh D. WechalekarJin Lu Original Article Open access 02 March 2023 Pages: 863 - 876
Long-term clinical outcomes of gastric mucosa-associated lymphoid tissue lymphoma in real-world experience Gi-June MinDonghoon KangSeok-Goo Cho Original Article Open access 25 February 2023 Pages: 877 - 888
Risks and outcomes of hospitalizations in patients with chronic lymphocytic leukemia admitted with immune thrombocytopenia: an analysis of the National Inpatient Sample Database Mohammad Ammad Ud DinAmir MahmudMichael Jaglal Original Article 13 February 2023 Pages: 889 - 895
Real-world outcomes of adult patients with acute lymphoblastic leukemia treated with a modified CALGB 10102 regimen Daniel R. ReedMargaux WoosterTimothy S. Pardee Original Article 01 March 2023 Pages: 897 - 906
Prognostic factors for patients with hematologic malignancies admitted to the intensive care unit: is allogeneic transplantation still a risk factor? Pei-Hua WuWen-Xuan HuoYou-Zhong An Original Article 09 February 2023 Pages: 907 - 916
Impact of age on hospitalization and outcomes post allogeneic hematopoietic cell transplantation outcome, a single center experience Eshrak Al-ShaibaniShiyi ChenRajat Kumar Original Article 23 February 2023 Pages: 917 - 926
The prognostic value of patient-reported outcomes in allogeneic hematopoietic stem cell transplantation: exploratory analysis of a randomized nutrition intervention trial Anne Marte GudmundstuenFabio EfficacePer Ole Iversen Original Article Open access 03 March 2023 Pages: 927 - 935
Improved Vδ2+ T cells recovery correlates to reduced incidences of mortality and relapse in acute myeloid leukemia after hematopoietic transplantation Keli YueHaitao GaoJiangying Liu Original Article 10 February 2023 Pages: 937 - 946
Pain: a neglected symptom in hemophilia Mustafa KurçaloğluMemiş Hilmi Atay Original Article 23 February 2023 Pages: 947 - 953
Analysis of hematologic adverse events reported to a national surveillance system following COVID-19 bivalent booster vaccination Jeremy W. JacobsGarrett S. BoothBrian D. Adkins Original Article 16 February 2023 Pages: 955 - 959
Tocilizumab, an IL6-receptor antibody, proved effective as adjuvant therapy for cytokine storm induced by severe infection in patients with hematologic malignancy Bingjie WangQian WangYujun Dong Original Article 03 March 2023 Pages: 961 - 966
Early leukoencephalopathy during daratumumab treatment in a patient with multiple myeloma Shanshan LiuHongwei ZhouFengyan Jin Letter to the Editor 08 February 2023 Pages: 967 - 969
High susceptibility of febrile neutropenia in Japanese patients receiving venetoclax plus azacitidine therapy for acute myeloid leukemia Kensuke MatsudaTakashi YoshidaKoichi Sugimoto Letter to the Editor 23 February 2023 Pages: 971 - 972
Combination venetoclax and olverembatinib (HQP1351) as a successful therapeutic strategy for relapsed/refractory (R/R) mixed-phenotype blast phase of chronic myeloid leukemia Tongtong ZhangHaixia ZhouShengli Xue Letter to the Editor 06 February 2023 Pages: 973 - 975
Rare forms of idiopathic multicentric Castleman disease presenting with intrahepatic cholestatic jaundice successfully treated with the bortezomib-based regimen: two case reports Xiao-hang LiuLu ZhangBo-ju Pan Letter to the Editor 07 February 2023 Pages: 977 - 979
Clonal evolution analysis of a rare acute promyelocytic leukemia patient transforming from essential thrombocythemia Rong ZhangYabin LiuKankan Wang Letter to the Editor 07 February 2023 Pages: 981 - 984